Newsletter | November 6, 2025

11.06.25 -- 2025: A Pivotal Year for Trial Tech Evolution

How eConsent Delivers Value For Sponsors

Electronic informed consent (eConsent) improves the experience for patients, caregivers, and clinical-trial staff — yet adoption remains hindered by several barriers. This article reviews the data substantiating eConsent’s positive impact on clinical trial outcomes and what's slowing uptake.

 

IRT: A New Approach To Meeting The Needs Of Early Phase Trials

Traditionally, IRT systems have not been used in early phase trials due to time and cost. However, as early phase studies become more complex, sponsors are re-evaluating the use of IRT. This piece outlines how one IRT solution can increase control, ease-of-use, and cost efficiencies versus manual processes.

 

VIDEO INSIGHTS

Successful Subject Creation With eCOA, eConsent, And IRT Process Flow

Watch a short walkthrough of how IRT and electronic Clinical Outcome Assessment (eCOA) solution on a unified platform delivery drives smoother study orchestration.

 

Innovations In IRT

As part of the inaugural Clinical Leader Solutions Showcase, IQVIA's Dan Pavitt explores the latest innovative techniques in trial design, delivery, conduct, and monitoring of clinical trials, plus a live demonstration of IQVIA’s mobile IP product.

 

SOLUTIONS

IQVIA Integrated Complete Consent IRT eCOA

See how integrated eConsent, IRT, and eCOA work together to improve study quality, accelerate decision making, and reduce site and sponsor burden.

• Request Information